These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Protective action of penicillin in arsenobenzol poisoning]. PARISI P Arch Ital Dermatol Sifilogr Venereol; 1950; 23(4):289-99. PubMed ID: 14772020 [No Abstract] [Full Text] [Related]
3. [Lesions in syphilis treatment with arsenobenzol; indications and contraindications in therapy]. FOLDVARI F Orv Hetil; 1951 Jul; 92(28):892-9. PubMed ID: 14863886 [No Abstract] [Full Text] [Related]
4. [Clinical evaluation of spirotrypan, a new arsenobenzol preparation]. FOLSCH F; GLASER J; KRIEGK HJ Z Haut Geschlechtskr; 1951 Apr; 10(7):288-92. PubMed ID: 14836949 [No Abstract] [Full Text] [Related]
5. [Treatment with arsenobenzol of vaccine-resistant Malta fever]. FERRETTI M; D'ANTUONO G Acta Med Ital Mal Infett Parassit; 1951 Mar; 6(3):67. PubMed ID: 14837685 [No Abstract] [Full Text] [Related]
6. [Follicular keratosis caused by arsenobenzol (illustration)]. WAGNER G Z Haut Geschlechtskr; 1950 Sep; 9(6):xxii. PubMed ID: 14789014 [No Abstract] [Full Text] [Related]
7. [Influence of splenectomy on the survival of rats subjected to a lethal dose of an arsenobenzol derivative]. MERKLEN FP; RATHERY M C R Seances Soc Biol Fil; 1951 Feb; 145(3-4):256-9. PubMed ID: 14839947 [No Abstract] [Full Text] [Related]
8. [Intrahepatic obstructive jaundice in arsenobenzol therapy]. ELLEGAST H; THALER H Dtsch Med Wochenschr; 1950 Dec; 75(51):1713-5. PubMed ID: 14802150 [No Abstract] [Full Text] [Related]
9. [Dermatosis due to arsenobenzol and gold treated with BAL; exanthema caused by BAL]. FOLDVARI F; THOROCZKAY N Ann Dermatol Syphiligr (Paris); 1950; 10(5):535-40. PubMed ID: 14790356 [No Abstract] [Full Text] [Related]
10. [Experimental and clinical studies on the use of arsenobenzol and bismuth in the penicillin therapy of syphilis]. MONCORPS ; HEITE Arch Dermatol Syph; 1950; 191():446-50. PubMed ID: 14790651 [No Abstract] [Full Text] [Related]
11. [BAL in the treatment of arsenobenzol poisoning]. FETTICH J Zdrav Vestn; 1952; 21(3-4):42-6. PubMed ID: 14931988 [No Abstract] [Full Text] [Related]
12. [Cerebral arsenobenzol autohemotherapy in progressive paralysis; definitive cure in a case of grave paralytic dementia; considerations on cerebral autohemotherapy]. MARIOTTI E Osp Psichiatr; 1951; 19(1):1-19. PubMed ID: 14863933 [No Abstract] [Full Text] [Related]
13. Clinical similarity and pathogenetic difference between the arsenobenzol urticaria and the nitritoid crisis. VAMOS L; RACZ S Acta Derm Venereol; 1949; 29(4):414-20. PubMed ID: 18119949 [No Abstract] [Full Text] [Related]
14. [Studies on jaundice due to arsenobenzol]. GRANA A Rass Dermatol Sifilogr; 1952; 5(5):279-86. PubMed ID: 13064418 [No Abstract] [Full Text] [Related]
15. [Clinical experiences with the new arsenobenzol preparation spirotrypan]. HEITE HJ; HULSBRINK H Dtsch Med Wochenschr; 1953 Apr; 78(17):643-6. PubMed ID: 13067950 [No Abstract] [Full Text] [Related]
16. [Experimental blood protein disorder caused by arsenobenzol]. CIACCIO I Minerva Dermatol; 1953 May; 28(5):Atti, 26-7. PubMed ID: 13086688 [No Abstract] [Full Text] [Related]
17. [Arsenobenzol and BAL; histochemical study in experimental animals]. BUCCELLATO G; TRIOLO G Rass Dermatol Sifilogr; 1951; 4(5):337-54. PubMed ID: 14942011 [No Abstract] [Full Text] [Related]
18. [Spirotrypan, a new arsenobenzol preparation in syphilis therapy]. SIEBERT G Med Klin; 1953 Aug; 48(32):1158-9. PubMed ID: 13086419 [No Abstract] [Full Text] [Related]
19. [The evaluation of liver damage in arsenobenzol therapy and its elimination]. LAZAROVITS L; KAROLYI I Borgyogy Venerol Sz; 1953 Mar; 7(2):43-4. PubMed ID: 13066522 [No Abstract] [Full Text] [Related]